Functional Brain PET Imaging Effectively Forecasts Which Vegetative Patients Can Recover Consciousness
By MedImaging International staff writers Posted on 27 Apr 2014 |
Image: A functional brain imaging technique known as positron emission tomography (PET) is a promising tool for determining which severely brain damaged individuals in vegetative states have the potential to recover consciousness (Photo courtesy of sonap / Fotolia).
Positron emission tomography (PET) has the potential for determining which brain damaged individuals in vegetative states have the potential to recover consciousness, according to new research.
The study’s findings were published online April 16, 2014, in the Lancet. It is the first time that researchers have assessed the diagnostic accuracy of functional brain imaging techniques in clinical practice. “Our findings suggest that PET imaging can reveal cognitive processes that aren’t visible through traditional bedside tests, and could substantially complement standard behavioral assessments to identify unresponsive or ‘vegetative’ patients who have the potential for long-term recovery,” stated study leader Prof. Steven Laureys, from the University of Liége (Belgium).
In severely brain-damaged individuals, judging the level of consciousness has proved challenging. Traditionally, bedside clinical examinations have been used to decide whether patients are in a minimally conscious state (MCS), in which there is some evidence of awareness and response to stimuli, or are in a vegetative state (VS) also known as unresponsive wakefulness syndrome, where there is neither, and the chance of recovery is much lower. But up to 40% of patients are misdiagnosed using these scans.
“In patients with substantial cerebral edema, prediction of outcome on the basis of standard clinical examination and structural brain imaging is probably little better than flipping a coin,” wrote Jamie Sleigh from the University of Auckland (New Zealand), and Catherine Warnaby from the University of Oxford (UK), in a linked comment.
The study evaluated whether two new functional brain imaging techniques—PET with the imaging agent fluorodeoxyglucose (FDG) and functional MRI (fMRI) during mental imagery tasks—could differentiate between vegetative and MCS in 126 patients with severe brain injury (81 in a MCS, 41 in a VS, and four with locked-in syndrome—a behaviorally unresponsive but conscious control group) referred to the University Hospital of Liége, from across Europe. The researchers then compared their results with the well-established standardized Coma Recovery Scale-Revised (CSR-R) behavioral test, considered the most confirmed and sensitive technique for discriminating very low awareness.
FDG-PET was better overall than fMRI in differentiating conscious from unconscious patients. Mental imagery fMRI was less sensitive at diagnosis of a MCS than FDG-PET (45% vs. 93%), and had less agreement with behavioral CRS-R scores than FDG-PET (63% vs. 85%). FDG-PET was about 74% accurate in predicting the extent of recovery within the next year, compared with 56% for fMRI.
Significantly, one-third of the 36 patients diagnosed as behaviorally unresponsive on the CSR-R test who were scanned with FDG-PET showed brain activity consistent with the presence of some consciousness. Nine patients in this group consequently recovered a reasonable level of consciousness.
According to Prof. Laureys, “We confirm that a small but substantial proportion of behaviorally unresponsive patients retain brain activity compatible with awareness. Repeated testing with the CRS-R complemented with a cerebral FDG-PET examination provides a simple and reliable diagnostic tool with high sensitivity towards unresponsive but aware patients. fMRI during mental tasks might complement the assessment with information about preserved cognitive capability, but should not be the main or sole diagnostic imaging method.”
The authors noted that the study was conducted in a specialist unit focusing on the diagnostic neuroimaging of disorders of consciousness and therefore deployment might be more challenging in less specialist units.
Commenting on the study Drs. Sleigh and Warnaby added, “From these data, it would be hard to sustain a confident diagnosis of unresponsive wakefulness syndrome solely on behavioral grounds, without PET imaging for confirmation ... [This] work serves as a signpost for future studies. Functional brain imaging is expensive and technically challenging, but it will almost certainly become cheaper and easier. In the future, we will probably look back in amazement at how we were ever able to practice without it.”
Related Links:
University of Liége
The study’s findings were published online April 16, 2014, in the Lancet. It is the first time that researchers have assessed the diagnostic accuracy of functional brain imaging techniques in clinical practice. “Our findings suggest that PET imaging can reveal cognitive processes that aren’t visible through traditional bedside tests, and could substantially complement standard behavioral assessments to identify unresponsive or ‘vegetative’ patients who have the potential for long-term recovery,” stated study leader Prof. Steven Laureys, from the University of Liége (Belgium).
In severely brain-damaged individuals, judging the level of consciousness has proved challenging. Traditionally, bedside clinical examinations have been used to decide whether patients are in a minimally conscious state (MCS), in which there is some evidence of awareness and response to stimuli, or are in a vegetative state (VS) also known as unresponsive wakefulness syndrome, where there is neither, and the chance of recovery is much lower. But up to 40% of patients are misdiagnosed using these scans.
“In patients with substantial cerebral edema, prediction of outcome on the basis of standard clinical examination and structural brain imaging is probably little better than flipping a coin,” wrote Jamie Sleigh from the University of Auckland (New Zealand), and Catherine Warnaby from the University of Oxford (UK), in a linked comment.
The study evaluated whether two new functional brain imaging techniques—PET with the imaging agent fluorodeoxyglucose (FDG) and functional MRI (fMRI) during mental imagery tasks—could differentiate between vegetative and MCS in 126 patients with severe brain injury (81 in a MCS, 41 in a VS, and four with locked-in syndrome—a behaviorally unresponsive but conscious control group) referred to the University Hospital of Liége, from across Europe. The researchers then compared their results with the well-established standardized Coma Recovery Scale-Revised (CSR-R) behavioral test, considered the most confirmed and sensitive technique for discriminating very low awareness.
FDG-PET was better overall than fMRI in differentiating conscious from unconscious patients. Mental imagery fMRI was less sensitive at diagnosis of a MCS than FDG-PET (45% vs. 93%), and had less agreement with behavioral CRS-R scores than FDG-PET (63% vs. 85%). FDG-PET was about 74% accurate in predicting the extent of recovery within the next year, compared with 56% for fMRI.
Significantly, one-third of the 36 patients diagnosed as behaviorally unresponsive on the CSR-R test who were scanned with FDG-PET showed brain activity consistent with the presence of some consciousness. Nine patients in this group consequently recovered a reasonable level of consciousness.
According to Prof. Laureys, “We confirm that a small but substantial proportion of behaviorally unresponsive patients retain brain activity compatible with awareness. Repeated testing with the CRS-R complemented with a cerebral FDG-PET examination provides a simple and reliable diagnostic tool with high sensitivity towards unresponsive but aware patients. fMRI during mental tasks might complement the assessment with information about preserved cognitive capability, but should not be the main or sole diagnostic imaging method.”
The authors noted that the study was conducted in a specialist unit focusing on the diagnostic neuroimaging of disorders of consciousness and therefore deployment might be more challenging in less specialist units.
Commenting on the study Drs. Sleigh and Warnaby added, “From these data, it would be hard to sustain a confident diagnosis of unresponsive wakefulness syndrome solely on behavioral grounds, without PET imaging for confirmation ... [This] work serves as a signpost for future studies. Functional brain imaging is expensive and technically challenging, but it will almost certainly become cheaper and easier. In the future, we will probably look back in amazement at how we were ever able to practice without it.”
Related Links:
University of Liége
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment